Head-To-Head Contrast: Top Glove Co. Bhd. (OTCMKTS:TGLVY) versus Bionano Genomics (NASDAQ:BNGO)

Top Glove Co. Bhd. (OTCMKTS:TGLVY) and Bionano Genomics (NASDAQ:BNGO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, profitability, valuation and risk.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Top Glove Co. Bhd. and Bionano Genomics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Top Glove Co. Bhd.	0	0	0	0	N/A
Bionano Genomics	0	1	2	0	2.67

Bionano Genomics has a consensus target price of $21.33, indicating a potential upside of 2,610.03%. Given Bionano Genomics’ higher probable upside, analysts plainly believe Bionano Genomics is more favorable than Top Glove Co. Bhd..

Valuation & Earnings

This table compares Top Glove Co. Bhd. and Bionano Genomics’ revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Top Glove Co. Bhd.	N/A	N/A	N/A	$1.15	0.55
Bionano Genomics	$36.12 million	1.19	-$232.49 million	($6.62)	-0.12

Top Glove Co. Bhd. has higher earnings, but lower revenue than Bionano Genomics. Bionano Genomics is trading at a lower price-to-earnings ratio than Top Glove Co. Bhd., indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Top Glove Co. Bhd. and Bionano Genomics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Top Glove Co. Bhd.	N/A	N/A	N/A
Bionano Genomics	-643.74%	-103.68%	-71.45%

Institutional and Insider Ownership

11.4% of Bionano Genomics shares are owned by institutional investors. 2.4% of Bionano Genomics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

About Top Glove Co. Bhd.

Top Glove Corporation Bhd., an investment holding company, manufactures, trades in, and sells gloves in Malaysia, Thailand, the People's Republic of China, and internationally. The company offers nitrile, latex, surgical, rubber, examination, medical, and vinyl gloves; concentrate and synthetic latex, formers, chemicals and chemical compounds, rubber dental dams, exercise bands, condoms, and rubber related products; packaging materials, boxes, and cartons; and disposable and medical face masks, engineering parts and rubber glove machinery, functional fillers, healthcare products, and homecare and personal care products. It also provides property investment and consultancy services, and electrical engineering works; clinical and specialist medical services; analytical, medical related consultancy, emergency medical, advisory, accommodation, management and trading, and value added services; management services in plantation sector; processing of plantation produce; and industrial forest plantation services, as well as forestry and industry services. In addition, the company trades in healthcare related products; distributes medical devices and products, and other hospital related products; operates as a special purpose vehicle solely for issuance of Perpetual Sukuk; organizes in-house trainings and public trainings/programs; and establishes and maintains fitness related business, including healthcare, slimming centers, gymnasiums, and other related activities. Further, it generates and supplies energy and electricity using biomass technology; and offers e-commerce services for glove trading and other healthcare products. Additionally, the company provides gamma irradiation services for sterilization of gloves and medical devices; acts as an agent in the sale of various goods; wholesales pharmaceutical goods; and buys and sells real estate. Top Glove Corporation Bhd. was founded in 1991 and is headquartered in Shah Alam, Malaysia.

About Bionano Genomics

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.